The incidence and direct medical cost of hospitalization due to rotavirus gastroenteritis in Kyoto, Japan, as estimated from a retrospective hospital study

Vaccine

Volumn 29, Issue 44, 2011, Pages 7807-7810

  Ito, Hisato ^a   Otabe, Osamu ^a   Katsumi, Yoshiki ^a   Matsui, Fumihiro ^a   Kidowaki, Satoshi ^a   Mibayashi, Akiko ^a   Nakagomi, Toyoko ^b   Nakagomi, Osamu ^b  

^a NANTAN GENERAL HOSPITAL   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Disease burden; Hospitalization; Immunization; Incidence rate; Rotavirus; Vaccine

Indexed keywords

ROTAVIRUS VACCINE; VIRUS ANTIGEN;

ACUTE GASTROENTERITIS; ARTICLE; CHILD; CONTROLLED STUDY; DIARRHEA; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; HOSPITALIZATION COST; HUMAN; IMMUNIZATION; JAPAN; MAJOR CLINICAL STUDY; MORBIDITY; NEWBORN; PEDIATRICIAN; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ROTAVIRUS INFECTION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GASTROENTERITIS; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; JAPAN; MALE; RETROSPECTIVE STUDIES; ROTAVIRUS INFECTIONS;

EID: 80053585514     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.07.105     Document Type: Article

References (15)

1. Tate J.E., Patel M.M., Steele A.D., Gentsch J.R., Payne D.C., Cortese M.M., et al. Global impact of rotavirus vaccines. Expert Rev Vaccines 2010, 9:395-407.
2. Curns A.T., Steiner C.A., Barrett M., Hunter K., Wilson E., Parashar U.D. Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states. J Infect Dis 2010, 201:1617-1624.
3. Wang F.T., Mast T.C., Glass R.J., Loughlin J., Seeger J.D. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States. Pediatrics 2010, 125:e208-e213.
4. Centers for Disease Control and Prevention Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2009, 58(RR-2):1-25.
5. Van Damme P., Giaquinto C., Huet F., Gothefors L., Maxwell M., Van der Wielen M., et al. Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study. J Infect Dis 2007, 195(Suppl. 1):S4-S16.
6. Giaquinto C., Van Damme P., Huet F., Gothefors L., Van der Wielen M. Costs of community-acquired pediatric rotavirus gastroenteritis in 7 European countries: the REVEAL study. J Infect Dis 2007, 195(Suppl. 1):S36-S44. REVEAL Study Group.
7. Giaquinto C., Callegaro S., Andreola B., Bernuzzi M., Cantarutti L., D'Elia R., et al. Prospective study of the burden of acute gastroenteritis and rotavirus gastroenteritis in children less than 5 years of age, in Padova, Italy. Infection 2008, 36:351-357.
8. Nakagomi T., Nakagomi O., Takahashi Y., Enoki M., Suzuki T., Kilgore P.E. Incidence and burden of rotavirus gastroenteritis in Japan, as estimated from a prospective sentinel hospital study. J Infect Dis 2005, 192(Suppl. 1):S106-S110.
9. Nakagomi T., Chang B.R., Nakagomi O. Rotavirus hospitalization and molecular epidemiology in northern Japan, 1987-1996. Vaccine 2009, 27(Suppl. 5):F93-F96.
10. Kamiya H., Nakano T., Inoue M., Kamiya H., Abd T.T., Patel M., et al. A retrospective evaluation of hospitalizations for acute gastroenteritis at 2 sentinel hospitals in central Japan to estimate the health burden of rotavirus. J Infect Dis 2009, 200(Suppl. 1):S140-S146.
11. Hiramoto I., Nakagomi T., Nakagomi O. Population-based estimates of the cumulative risk of hospitalization potentially associated with rotavirus diarrhea among children living in two cities in Akita Prefecture, Japan. Jpn J Infect Dis 2005, 58:73-77.
12. Giaquinto C., van Damme P. Age distribution of paediatric rotavirus gastroenteritis cases in Europe: the REVEAL study. Scand J Infect Dis 2010, 42:142-147. REVEAL Study Group.
13. Vesikari T., Karvonen A., Ferrante S.A., Kuter B.J., Ciarlet M. Sustained efficacy of the pentavalent rotavirus vaccine, RV5, up to 3.1 years following the last dose of vaccine. Pediatr Infect Dis J 2010, 29:957-963.
14. ®, in Finnish infants up to 3 years of age: the Finnish Extension Study. Eur J Pediatr 2010, 169:1379-1386.
15. Nakanishi K., Tsugawa T., Honma S., Nakata S., Tatsumi M., Yoto Y., et al. Detection of enteric viruses in rectal swabs from children with acute gastroenteritis attending the pediatric outpatient clinics in Sapporo, Japan. J Clin Virol 2009, 46:94-97.